MedPath

TEAM-Red, a Remotely Delivered Self-management Program for Depressed Black Women at Risk for Hypertension

Not Applicable
Recruiting
Conditions
Depression
Interventions
Behavioral: TEAM-Red
Other: Waitlist
Registration Number
NCT05488782
Lead Sponsor
Jennifer B. Levin
Brief Summary

The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
82
Inclusion Criteria
  1. Registered on Research Goes Red;
  2. Self-identified African American female ages 18-49;
  3. current depression as measured by a score of ≥10 on the 9-item Patient Health Questionnaire (PHQ-9),
  4. Have at least one of the following self or chart-recorded HTN risk factors: body mass index (BMI) greater ≥ 30, HbA1c >5.75, at least one outpatient reading of systolic blood pressure (BP) ≥ 130 mm Hg or diastolic ≥90 mmHg, current smoker, or LDL ≥100 mg/dl in the last 12 months;
  5. Are able to participate in study procedures.

Phase 1

Exclusion Criteria
  1. Unwilling/unable to provide informed consent;
  2. Pregnancy;
  3. Imminent suicide risk,
  4. A current diagnosis of hypertension or use of antihypertensive medications.

Phase 2 Inclusion Criteria

  1. Self-identified AA female ages 18-49;
  2. Endorses either: a past or current history of depression, current depression as measured by a score of at least a 5 on the 9-item Patient Health Questionnaire (PHQ-9), or indicate feelings of stress or discrimination that impact their functioning
  3. Have at least one of the following self or chart-recorded HTN risk factors: BMI greater ≥ 30,26 HbA1c >5.75,27 at least one outpatient reading of systolic BP ≥ 130 mm Hg or diastolic ≥90 mmHg, current smoker, or LDL ≥100 mg/dl in the last 12 months;
  4. Are able to participate in study procedures.

Phase 2 Exclusion Criteria

  1. Unwilling/unable to provide informed consent;
  2. Pregnancy;
  3. Imminent suicide risk,
  4. A current diagnosis of HTN or use of antihypertensive medications.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
TEAM-RedTEAM-RedFive 60-minute group sessions with 6-10 patients. These sessions will be held weekly and delivered remotely via videoconference
Enhanced Waitlist (eWL)WaitlistAfter the week 12 follow up visit, subjects in the Waitlist group will receive the TEAM Red intervention
Primary Outcome Measures
NameTimeMethod
Phase 1 TEAM vs WL change in 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-upBaseline to 12 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 1 change in 9-item Patient Health Questionnaire (PHQ-9) total score at 24-week follow upBaseline to 24 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 2 TEAM-Red vs eWL 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-upBaseline to 12 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 2 change in 9-item Patient Health Questionnaire (PHQ-9) total score at 24-week follow-upBaseline to 24 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 2 TEAM-Red vs eWL 10-item Perceived Stress Scale (PSS-10) total score at 12-week follow-upBaseline to 12 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Phase 2 change in 10-item Perceived Stress Scale (PSS-10) total score at 24-week follow upBaseline to 24 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Secondary Outcome Measures
NameTimeMethod
Phase 1 TEAM-Red vs eWL 10-item Perceived Stress Scale (PSS-10) total score at 12-week follow-upBaseline to 12 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Phase 1 change in 10-item Perceived Stress Scale (PSS-10) total score at 24-week follow upBaseline to 24 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Phase 1 TEAM-Red vs eWL 12-item Short Form Survey (SF-12) mental component score at 12-week follow upBaseline to 12 weeks

SF-12 mental component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to mental health

Phase 1 TEAM-Red vs eWL 12-item Short Form Survey (SF-12) physical component score at 12-week follow upBaseline to 12 weeks

SF-12 physical component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to physical health

Phase 1 change in 12-item Short Form Survey (SF-12) mental component score at 24-week follow upBaseline to 24 weeks

SF-12 mental component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to mental health

Phase 1 change in 12-item Short Form Survey (SF-12) physical component score at 24-week follow upBaseline to 24 weeks

SF-12 physical component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to physical health

Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) mental component score at 12-week follow-upBaseline to 12 weeks

SF-12 mental component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to mental health

Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) physical component score at 12-week follow-upBaseline to 12 weeks

SF-12 physical component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to physical health

Phase 2 change in 12-item Short Form Survey (SF-12) mental component score at 24-week follow upBaseline to 24 weeks

SF-12 mental component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to mental health

Phase 2 change in 12-item Short Form Survey (SF-12) physical component score at 24-week follow upBaseline to 24 weeks

SF-12 physical component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to physical health

Phase 1 and Phase 2 TEAM-Red vs eWL change in 9-item Patient Health Questionnaire (PHQ-9) total score at 12-week follow-upBaseline to 12 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 1 and Phase 2 change in 9-item Patient Health Questionnaire (PHQ-9) total score at 24-week follow upBaseline to 24 weeks

PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression

Phase 1 and Phase 2 TEAM-Red vs eWL change in 10-item Perceived Stress Scale (PSS-10) total score at 12-week follow-upBaseline to 12 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Phase 1 and Phase 2 change in 10-item Perceived Stress Scale (PSS-10) total score at 24-week follow upBaseline to 24 weeks

PSS-10 total scores ranges from 0 to 40 with a higher score indicating a higher level of perceived stress

Phase 1 and Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) mental component score at 12-week follow-upBaseline to 12 weeks

SF-12 mental component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to mental health

Phase 1 and Phase 2 TEAM-Red vs eWL change in 12-item Short Form Survey (SF-12) physical component score at 12-week follow-upBaseline to 12 weeks

SF-12 physical component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to physical health

Phase 1 and Phase 2 change in 12-item Short Form Survey (SF-12) mental component score at 24-week follow upBaseline to 24 weeks

SF-12 mental component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to mental health

Phase 1 and Phase 2 change in 12-item Short Form Survey (SF-12) physical component score at 24-week follow upBaseline to 24 weeks

SF-12 physical component score ranges from 0 to 100, with higher scores indicating a better quality of life as it relates to physical health

Trial Locations

Locations (1)

University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath